Benadryl
Hematopoietic Cell Transplantation Recipient
M.D. Anderson Cancer CenterPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Hematopoietic Cell Transplantation Recipient cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DEXAMETHASONE Indiana University | Phase 2 | BB |
cc-5013 Stanford University | Phase 2 | BB |
Cediranib Ohio State University Comprehensive Cancer Center | Phase 2 | BB |
mln9708 Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 2 | B |
Ibrutinib Andrew Rezvani | Phase 2 | B |
View all 12 →
Same molecule, other indications
Benadryl is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →